NCT02784795 2025-08-21A Study of LY3039478 in Participants With Advanced or Metastatic Solid TumorsEli Lilly and CompanyPhase 1 Terminated94 enrolled 28 charts
NCT00276861 2017-02-08Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon CancerUniversity of MiamiPhase 2 Terminated10 enrolled 7 charts